THRA and breast carcinoma: Similar point estimates were seen for breast cancer specific mortality and there was evidence of effect modification (p < 0.05) by ER-status on THRα-2 expression both regarding breast cancer specific mortality and overall mortality in all analyses (unadjusted, age adjusted and adjusted for age, tumor size and ALNI).